Stone RM - Search Results

1

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

Banerji V, Frumm SM, Ross KN, Li LS, Schinzel AC, Hahn CK, Kakoza RM, Chow KT, Ross L, Alexe G, Tolliday N, Inguilizian H, Galinsky I, Stone RM, DeAngelo DJ, Roti G, Aster JC, Hahn WC, Kung AL, Stegmaier K. Banerji V, et al. Among authors: stone rm. J Clin Invest. 2012 Mar;122(3):935-47. doi: 10.1172/JCI46465. Epub 2012 Feb 13. J Clin Invest. 2012. PMID: 22326953 Free PMC article.

2

Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation.

Kharbanda S, Nakamura T, Stone R, Hass R, Bernstein S, Datta R, Sukhatme VP, Kufe D. Kharbanda S, et al. J Clin Invest. 1991 Aug;88(2):571-7. doi: 10.1172/JCI115341. J Clin Invest. 1991. PMID: 1864967 Free PMC article.

3

Fatal disseminated mycobacterial infection following intravesical bacillus Calmette-Guerin.

Deresiewicz RL, Stone RM, Aster JC. Deresiewicz RL, et al. Among authors: stone rm. J Urol. 1990 Dec;144(6):1331-3; discussion 1333-4. doi: 10.1016/s0022-5347(17)39732-x. J Urol. 1990. PMID: 2231918

4

Detection of tumor necrosis factor gene expression at a cellular level in human acute myeloid leukemias.

Wakamiya N, Stone R, Takeyama H, Spriggs D, Kufe D. Wakamiya N, et al. Leukemia. 1989 Jan;3(1):51-6. Leukemia. 1989. PMID: 2642577

5

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM. Inhorn RC, et al. Among authors: stone rm. Blood. 1995 Apr 1;85(7):1881-7. Blood. 1995. PMID: 7661940 Free article. Review.

6

The approach to the elderly patient with acute myeloid leukemia.

Stone RM, Mayer RJ. Stone RM, et al. Hematol Oncol Clin North Am. 1993 Feb;7(1):65-79. Hematol Oncol Clin North Am. 1993. PMID: 7680642 Review.

7

Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.

Stone RM, Bernstein SH, Demetri G, Facklam DP, Arthur K, Andersen J, Aster JC, Kufe D. Stone RM, et al. Leuk Res. 1994 Oct;18(10):769-76. doi: 10.1016/0145-2126(94)90059-0. Leuk Res. 1994. PMID: 7934135 Clinical Trial.

8

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al. Stone RM, et al. J Clin Oncol. 1994 Dec;12(12):2535-42. doi: 10.1200/JCO.1994.12.12.2535. J Clin Oncol. 1994. PMID: 7989927

9

All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.

Yang KD, Mizobuchi T, Kharbanda SM, Datta R, Huberman E, Kufe DW, Stone RM. Yang KD, et al. Among authors: stone rm. Blood. 1994 Jan 15;83(2):490-6. Blood. 1994. PMID: 8286746 Free article.

10

Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells.

Kharbanda S, Saleem A, Emoto Y, Stone R, Rapp U, Kufe D. Kharbanda S, et al. J Biol Chem. 1994 Jan 14;269(2):872-8. J Biol Chem. 1994. PMID: 8288641 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters